Indication extensions |
Urothelial cancer, unresectable locally advanced or metastatic transitional cell carcinoma - second-line
Gastric cancer - first-line
Gastric cancer - third-line
Head and neck (or upper airways tract) cancers, locally advanced - first-line
Non-small cell lung cancer (NSCLC) - PD-L1-positive, first-line & second-line
Treatment of adult patients with renal cell carcinoma (RCC) 1L. Advanced, unresectable, in combination with axitinib. |